CAG
LH icon

Crestwood Advisors Group’s Labcorp LH Stock Holding History

Crestwood Advisors Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$595K Sell
2,125
-198
-9% -$52K 0.01% 438
2026
Q1 		$620K Buy
2,323
+90
+4% +$24.4K 0.01% 371
2025
Q4 		$560K Buy
2,233
+928
+71% +$246K 0.01% 368
2025
Q3 		$375K Buy
1,305
+151
+13% +$40.5K 0.01% 414
2025
Q2 		$303K Sell
1,154
-47
-4% -$11.4K 0.01% 444
2025
Q1 		$280K Buy
1,201
+22
+2% +$5.34K 0.01% 440
2024
Q4 		$270K Buy
1,179
+246
+26% +$56.4K 0.01% 402
2024
Q3 		$209K Buy
+933
New +$205K ﹤0.01% 426
2024
Q2 		– Sell
-999
Closed -$218K – 438
2024
Q1 		$218K Sell
999
-129
-11% -$28.4K ﹤0.01% 401
2023
Q4 		$256K Sell
1,128
-7
-0.6% -$1.47K 0.01% 348
2023
Q3 		$228K Buy
+1,135
New +$239K 0.01% 327

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Crestwood Advisors Group's LH Position: Q2 2026 in Review

Crestwood Advisors Group reduced its Labcorp (LH) stake by 8.5% in Q2 2026, selling an estimated $52K and leaving 2,125 shares worth $595K. The position accounts for 0.01% of the portfolio, ranked #438.

Crestwood Advisors Group first reported a position in LH in Q3 2023 and has held it in 11 quarters since. The position peaked at $620K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Crestwood Advisors Group held 2,125 shares of Labcorp worth $595K as of Q2 2026.
  • Crestwood Advisors Group sold 198 Labcorp shares in Q2 2026, an estimated $52K.
  • Labcorp made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #438 holding.
  • Crestwood Advisors Group first reported a position in Labcorp in Q3 2023 and has held it in 11 quarters since.
  • Crestwood Advisors Group's Labcorp position peaked at $620K in Q1 2026.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.